Markets2 min read

Cannabis ETFs Rally on Trump Rescheduling Momentum

Major marijuana ETFs surge as Trump administration signals potential federal rescheduling action, driving institutional investment flows.

May 3, 2026 at 1:31 PMCannabismarketcap

Cannabis exchange-traded funds are experiencing their strongest rally in months as market participants price in accelerated federal rescheduling under the Trump administration. The AdvisorShares Pure US Cannabis ETF (MSOS) and ETFMG Alternative Harvest ETF (MJ) lead sector gains, with institutional money flowing back into cannabis investments after months of cautious positioning.

The ETF momentum reflects broader institutional confidence that Trump's business-friendly approach will expedite the rescheduling process that stalled under previous leadership. Unlike individual cannabis stocks that carry company-specific risks, ETFs provide diversified exposure to the regulatory upside while mitigating single-name volatility. This structure appeals to institutional investors who want cannabis exposure without picking winners in a fragmented market.

Fund flows into cannabis ETFs typically precede broader sector rallies, as institutional capital seeks liquid entry points before regulatory catalysts materialize. The current ETF performance suggests portfolio managers are positioning for a potential rescheduling announcement that could unlock banking services, reduce tax burdens, and enable interstate commerce for cannabis operators.

The ETF rally also signals renewed appetite for U.S. cannabis exposure over Canadian alternatives, which dominated fund allocations during earlier legalization cycles. American operators stand to benefit most from federal rescheduling, making domestically-focused ETFs the preferred vehicle for capturing regulatory upside.

Sustained ETF performance will depend on concrete policy actions rather than speculation. However, the current fund flows indicate institutional investors view the Trump administration's cannabis stance as materially different from previous regulatory approaches, creating momentum that could persist through the rescheduling timeline.